Progesterone Receptor Negative Terminated Phase 1 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01238133Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast CancerTreatment